Preoperative angiotensin-blocking drug therapy is not associated with atrial fibrillation after cardiac surgery

American Heart Journal

Volumn 160, Issue 2, 2010, Pages

  Rader, Florian ^a,c   Van Wagoner, David R ^b   Gillinov, A Marc ^b   Blackstone, Eugene H ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CARDIOVERSION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PREOPERATIVE CARE; PRIORITY JOURNAL; RISK; STRATIFIED SAMPLE; STROKE; TREATMENT OUTCOME;

EID: 77955464196     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.05.033     Document Type: Article

References (25)

1. Connolly S.J., Cybulsky I., and Lamy A. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-blocker length of stay (BLOS) study Am Heart J 145 2003 226 232
2. Mitchell L.B., Exner D.V., and Wyse D.G. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial JAMA 294 2005 3093 3100
3. Miceli A., Capoun R., and Fino C. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting J Am Coll Cardiol 54 2009 1778 1784
4. Doughan A.K., Harrison D.G., and Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction Circ Res 102 2008 488 496
5. Johar S., Cave A.C., and Narayanapanicker A. Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase FASEB J 20 2006 1546 1548
6. Shi Y., Li D., and Tardif J.C. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure Cardiovasc Res 54 2002 456 461
7. Palmas W., Ma S., and Psaty B. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis Am J Hypertens 20 2007 233 241
8. Ozaydin M., Dede O., and Varol E. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation Int J Cardiol 127 2008 362 367
9. White C.M., Kluger J., and Lertsburapa K. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III Eur J Cardiothorac Surg 31 2007 817 820
10. Coleman C.I., Makanji S., and Kluger J. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation Ann Pharmacother 41 2007 433 437
11. Raja S.G., and Fida N. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg 7 2008 470 475
12. Passman R., Beshai J., and Pavri B. Predicting post-coronary bypass surgery atrial arrhythmias from the preoperative electrocardiogram Am Heart J 142 2001 806 810
13. Blackstone E.H. Comparing apples and oranges J Thorac Cardiovasc Surg 123 2002 8 15
14. Mathew J.P., Fontes M.L., and Tudor I.C. A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
15. Aranki S.F., Shaw D.P., and Adams D.H. Predictors of atrial fibrillation after coronary artery surgery. current trends and impact on hospital resources Circulation 94 1996 390 397
16. Jongnarangsin K, Oral H. Postoperative atrial fibrillation. Med Clin North Am. 2008 Jan;92(1):87,99, x-xi.
17. Osranek M., Fatema K., and Qaddoura F. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study J Am Coll Cardiol 48 2006 779 786
18. Wu Z.K., Iivainen T., and Pehkonen E. Fibrillation in patients subjected to coronary artery bypass grafting J Thorac Cardiovasc Surg 126 2003 1477 1482
19. Kalman J.M., Munawar M., and Howes L.G. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation Ann Thorac Surg 60 1995 1709 1715
20. Ucar H.I., Tok M., and Atalar E. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery Heart Surg Forum 10 2007 E131 E135
21. Magee MJ, Herbert MA, Dewey TM, et al. Atrial fibrillation after coronary artery bypass grafting surgery: development of a predictive risk algorithm. Ann Thorac Surg. 2007 May;83(5):1707,12; discussion 1712.
22. Goette A., Juenemann G., and Peters B. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery Cardiovasc Res 54 2002 390 396
23. Sezai A., Hata M., and Niino T. Study of factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention J Thorac Cardiovasc Surg 137 2009 895 900
24. Kumagai K., Nakashima H., and Urata H. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J Am Coll Cardiol 41 2003 2197 2204
25. Nakashima H., Kumagai K., and Urata H. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2000 2612 2617